Outlook Therapeutics (OTLK) Q2 2025 Earnings

May 15Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.03
-0.82
-0.61
-0.4

Details

Expected EPS
-0.54282
Actual EPS
-0.4
Surprise EPS
0.14
Surprise Percent
+26.31%

Description

⁨Outlook Therapeutics⁩ (⁦OTLK⁩) has reported earnings of ⁦-0.4⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts